SFA — Sopharma AD Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMid CapHigh Flyer

Annual balance sheet for Sopharma AD, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	fx Final	fx Final
Cash
Cash and Equivalents
Cash and Short Term Investments	19.3	10.1	65.9	18.2	36.6
Net Total Accounts Receivable
Net Total Receivables	129	127	149	165	239
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	292	293	402	434	557
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	185	192	183	201	211
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	616	641	774	918	1,063
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	217	208	311	394	430
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	285	281	397	500	577
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	331	360	378	418	486
Total Liabilities & Shareholders' Equity	616	641	774	918	1,063
Total Common Shares Outstanding